GMED
Globus Medical
NYSE: GMED · HEALTHCARE · MEDICAL DEVICES
$74.19
+0.86% today
Updated 2026-09-11
Market cap
$10.08B
P/E ratio
19.19
P/S ratio
3.20x
EPS (TTM)
$3.91
Dividend yield
—
52W range
$54 – $101
Volume
1.5M
Globus Medical (GMED) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$74.19
12-Month target
$90.01
2030 Target
—
Intrinsic (DCF)
$140.62
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0B | $1.0B | $1.6B | $2.5B | $2.9B | $3.5B | $4.2B | $5.1B | $6.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 19.19x (capped 25x) · Margin: 17.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.